ACTRN12605000600640
Completed
Phase 3
A prospective randomised controlled, double-blind study of Parecoxib versus placebo for postoperative analgesia following craniotomy surgery.
Department of Anaesthesia, St Vincent's Hospital Melbourne0 sites82 target enrollmentOctober 5, 2005
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Anaesthesia, St Vincent's Hospital Melbourne
- Enrollment
- 82
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Alert and orientated, patients presenting for elective craniotomy.
Exclusion Criteria
- •Allergy or contraindication to NSAID's, sulphonamides or morphine.Combination ACE inhibitors and diuretics OR either an ACE inhibitor or diuretic if over 70 years oldAsthma if aggrevated by NSAID's or never taken NSAID'sSignificamt peptic ulcer diseaseRenal impairmentChronic pain conditions or taking oral morphine or NSAID's taken on day of surgeryNon English speaking or unable to understand Visual Analogue ScoreIschaemic Heart Diseae or Cerebrovascular DiseaseAny preoperative confusion or sedation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective randomised, double-blind controlled trial of intravenous aminophylline versus placebo in patients with acute exacerbations of COPDISRCTN17312089Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)80
Completed
Not Applicable
A prospective double-blinded randomised controlled trial to assess the efficacy of pre-emptive analgesia in forefoot surgeryISRCTN47246491Record Provided by the NHSTCT Register - 2006 Update - Department of Health80
Completed
Not Applicable
A randomised, prospective, double-blind controlled study evaluating the effectiveness of spinal endoscopy with adhesiolysis for the treatment of chronic low back paiISRCTN16558617Institutional Review Board of Ambulatory Surgery Center (USA)83
Withdrawn
Not Applicable
A prospective randomised double-blind, double-dummy, placebo-controlled crossover study to determine whether Glucagon-like peptide-1 (GLP-1) stimulates or suppresses pancreatic exocrine function in health.ACTRN12614000815662Dr Adam Deane15
Recruiting
Phase 1
A prospective, double-blind, randomized controlled clinical study of Shenshuai II granule in delaying the progression of chronic glomerulonephritis (CKD3 stage)ITMCTR2000003740Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine